Wang, C., Liu, Y., Guo, W., Zhu, X., Ahuja, N., & Fu, T. (2019). MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer. Cancer Manag Res.
Stile di citazione ChicagoWang, Chuntao, Yanliang Liu, Wenyi Guo, Xu Zhu, Nita Ahuja, e Tao Fu. "MAPT Promoter CpG Island Hypermethylation Is Associated With Poor Prognosis in Patients With Stage II Colorectal Cancer." Cancer Manag Res 2019.
Citazione MLAWang, Chuntao, et al. "MAPT Promoter CpG Island Hypermethylation Is Associated With Poor Prognosis in Patients With Stage II Colorectal Cancer." Cancer Manag Res 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.